Skip to content
A Green Sign – Lifestyle
Author:
Export Genius LLC
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
August 21, 2026
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
Export Genius Launched AI-Powered Smart Search to Simplify Global Trade Discovery
April 21, 2026